Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
St. Francis Medical Technologies was a medical device company specializing in the development of minimally invasive surgical implants for the treatment of spinal disorders. The company is best known for developing the X-STOP Interspinous Process Decompression (IPD) System, which became the first FDA-approved interspinous spacer for treating lumbar spinal stenosis. The X-STOP device was designed to be implanted between the spinous processes to prevent painful spinal extension while maintaining mobility. In 2007, the company was acquired by Kyphon for approximately $725 million, and its technology was subsequently integrated into Medtronic's spinal portfolio following Medtronic's acquisition of Kyphon later that same year.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St. Francis Medical Technologies.